Psychedelic experience

A psychedelic experience (known colloquially as a trip) is a temporary altered state of consciousness induced by the consumption of a psychedelic substance (most commonly LSD, mescaline, psilocybin mushrooms, or DMT).[citation needed] For example, an acid trip is a psychedelic experience brought on by the use of LSD, while a mushroom trip is a psychedelic experience brought on by the use of psilocybin. Psychedelic experiences feature alterations in normal perception such as visual distortions and a subjective loss of self-identity, sometimes interpreted as mystical experiences. Psychedelic experiences lack predictability, as they can range from being highly pleasurable (known as a good trip) to frightening (known as a bad trip). The outcome of a psychedelic experience is heavily influenced by the person's mood, personality, expectations, and environment (also known as set and setting).[1]

Researchers have interpreted psychedelic experiences in light of a range of scientific theories, including model psychosis theory, filtration theory, psychoanalytic theory, entropic brain theory, integrated information theory, and predictive processing. Psychedelic experiences are also induced and interpreted in religious and spiritual contexts.

Along with psilocybin's unique effect on the state of mind, psilocybin has been subject to the idea of being used for therapeutic treatments. This rapidly developing field of psilocybin-assisted therapy is worth mentioning due to the promising results of studies targeting a variety of mental disorders like depression [2], post-traumatic stress disorder (PTSD)[3], and obsessive-compulsive disorder(OCD) [4].

  1. ^ "LSD | Michigan Medicine".
  2. ^ Costa, Sabrina Correa da; Oesterle, Tyler; Rummans, Teresa A.; Richelson, Elliot; Gold, Mark (15 September 2022). "Psychedelic drugs for psychiatric disorders". Journal of the Neurological Sciences. 440. doi:10.1016/j.jns.2022.120332. ISSN 0022-510X. PMID 35841696.
  3. ^ Henner, Ryan L.; Keshavan, Matcheri S.; Hill, Kevin P. (15 August 2022). "Review of potential psychedelic treatments for PTSD". Journal of the Neurological Sciences. 439. doi:10.1016/j.jns.2022.120302. ISSN 0022-510X. PMID 35700643.
  4. ^ Khan, Iman; Jaura, Taimoor Asif; Tukruna, Alaa; Arif, Aabiya; Tebha, Sameer Saleem; Nasir, Sameen; Mukherjee, Dattatreya; Masroor, Nadia; Yosufi, Abubakr (5 April 2023). "Use of Selective Alternative Therapies for Treatment of OCD". Neuropsychiatric Disease and Treatment. 19: 721–732. doi:10.2147/NDT.S403997. PMID 37041856.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne